The Malaria Genomic Epidemiology Network (MalariaGEN) is investigating how genetic variation affects the biology and epidemiology of malaria, and using this knowledge to develop tools to control the disease.
Understanding the evolutionary battle between all three malaria genomes – human, parasite and mosquito – can help inform malaria control interventions.
We're studying the human genome to better understand the genetic factors that help people to resist severe malaria – information that could provide vital clues about the molecular mechanisms of immunity and accelerate the development of an effective vaccine.
We're studying genetic variation in the Anopheles mosquitoes that transmit malaria in order to better understand important evolutionary processes, such as how these mosquitoes adapt to resist infection with malaria parasites and survive insecticides.
We're investigating the biological consequences of genetic variation in the Plasmodium parasites that cause malaria, in order to answer crucial questions about malaria transmission and drug resistance.
A great manuscript providing a solid software framework to explore large scale genome variation data #Ag1000G https://t.co/WJE0FjjB9Z
23 Jun 2017
RT @KEMRI_Wellcome: Prof. Tom discusses MalariaGEN study that covers 13 sites across the Globe including Kilifi. Work still ongoing... https://t.co/OFWV9eAbuT
RT @MalariaAtlas: After 70yrs of dormancy, Plasmodium vivax research awakens. News from Day1 Intl Conf on P.#vivax Research in Brazil… https://t.co/sutIJR7Ysj
